This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
User:Michael Strong/TB
From Proteopedia
Michael Strong (Talk | contribs)
(New page: Web Supplement to:<br> '''Comprehensive Structural Analysis of Drug-Resistant Mutations in ''Mycobacterium tuberculosis''. Michael Strong 1,2, Andreas Sandgren 3,4, James E. Galagan 5,6, ...)
Next diff →
Revision as of 16:55, 15 September 2011
Web Supplement to:
Comprehensive Structural Analysis of Drug-Resistant Mutations in Mycobacterium tuberculosis.
Michael Strong 1,2, Andreas Sandgren 3,4, James E. Galagan 5,6, Mark Borowsky 5,7,8, George M. Church 2, Megan B. Murray 3
1.Center for Genes, Environment, and Health, National Jewish Health, Denver, CO, 80206,
2.Department of Genetics, Harvard Medical School, Boston, MA 02115,
3.Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115,
4.European Centre for Disease Prevention and Control,
5.Broad Institute of MIT and Harvard, Cambridge, MA, 02142,
6.College of Engineering, Boston University, Boston, MA, 02118,
7.Department of Molecular Biology, Massachusetts General Hospital, Boston, MA, 02114,
8.Department of Genetics, Massachusetts General Hospital, Boston, MA, 02114.
Please click on the GREEN links to see the structural details described.
RpoB homology model with Rifampin bound
|
GidB homology model with S-adenosylmethionine bound
|
RpsL homology model with streptomycin
|
InhA crystal structure with ETH-NAD bound
|
InhA crystal structure with INH-NAD bound
|
GyrA crystal structure
|
KatG crystal structure with heme bound
|
PncA crystal structure
|
